Rxo (RXO) Gross Margin (2021 - 2025)
Rxo (RXO) has disclosed Gross Margin for 5 consecutive years, with 18.11% as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Gross Margin fell 49.0% year-over-year to 18.11%, compared with a TTM value of 19.7% through Dec 2025, down 195.0%, and an annual FY2025 reading of 19.7%, down 195.0% over the prior year.
- Gross Margin was 18.11% for Q4 2025 at Rxo, down from 19.99% in the prior quarter.
- Across five years, Gross Margin topped out at 26.26% in Q2 2022 and bottomed at 18.11% in Q4 2025.
- Average Gross Margin over 5 years is 22.61%, with a median of 23.44% recorded in 2024.
- The sharpest move saw Gross Margin surged 402bps in 2022, then crashed -543bps in 2024.
- Year by year, Gross Margin stood at 20.8% in 2021, then rose by 19bps to 24.82% in 2022, then dropped by -3bps to 24.03% in 2023, then decreased by -23bps to 18.6% in 2024, then dropped by -3bps to 18.11% in 2025.
- Business Quant data shows Gross Margin for RXO at 18.11% in Q4 2025, 19.99% in Q3 2025, and 21.21% in Q2 2025.